Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Explore cost differences between SP 500 ETFs and index funds for IRAs. We'll cover fees, tax efficiency, and practical considerations for retirement investing.
24,354 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Bank of America and Ford recently flashed bullish signals after their golden crosses, but retirees must weigh income ...
Regulatory developments in 2026 are poised to redefine demand for BlackRock's ETHA ETF, as the SEC weighs staking rul...
CNBS traders are weighing a high-conviction cannabis theme against a thin dividend base. The ETF leans on one rent-pr...
A glamorous Basel moment offers more than photos; it’s a lens into personal finance. Discover lessons from bianca cen...
A sudden medical scare highlights a universal truth: emergencies don’t come with a plan. This piece breaks down how t...
A focused look at a large institutional bet on Indivior, the logic behind the $143 million investment, and how such m...
A JPMorgan Private Bank view argues that the 2026 rally is driven by earnings strength, with a base-case S&P 500 arou...
The S&P 500 trades at 22x forward earnings, but a deeper look at cash flow reveals a 32x multiple, driven by AI-relat...
When high-profile weddings grab headlines, they also reveal valuable money lessons. This article breaks down budgetin...
Warren Buffett's move into a big oil stock has investors buzzing. We break down what this means for long-term fans of...
A new stake in VOYA Financial by Gator Capital Management is turning heads among investors. This article breaks down ...